动物保健市场规模（按地区、范围和预测）

动物药品的市场规模及预测

2023 年动物保健市场规模价值为 467.4 亿美元，预计到 2031 年将达到 850.5 亿美元，2024 年至 2031 年的复合年增长率为 7.77%。兽医学是研究动物健康和福利的医学分支。诊断、治疗、预防和管理各种动物（包括宠物、农场动物、野生动物和动物园动物）的疾病和伤害。兽医学应用解剖学、生理学、病理学、药理学和外科学等多个学科的思想和程序来解决动物独特的健康课题。兽医促进动物福利，透过控制人畜共患疾病（可在动物和人类之间传播的疾病）保护公众健康，并透过牲畜检查和监管确保食品安全，并在为科学研究做出贡献方面发挥着重要作用。

此外，兽医学不仅限于临床护理，还包括动物行为、营养、繁殖和流行病学，满足单一动物和动物群体的整体健康需求。

全球兽药市场动态

主要市场驱动因子

增加宠物饲养和人性化：

全球范围内宠物拥有量的不断增长，加上人们将宠物视为家庭成员的日益人性化，推动了兽药的需求。这一趋势将鼓励更频繁、更全面的宠物医疗保健和健康检查，从而增加对兽医产品和服务的需求。

动物医学的进展：

动物诊断、药物和疫苗技术的进步提高了兽医护理的有效性和效率。远距医疗、穿戴式健康监测器和先进的外科手术正在透过改善治疗结果和增加可用的服务范围来促进兽医保健市场的发展，从而推动市场成长。

提高对动物健康与福利的认识：

宠物主人和农民越来越意识到动物健康和福利的重要性，从而对积极主动和预防性的医疗保健方法产生了需求。这种日益增强的认知推动了对疫苗接种、营养补充剂和定期健康检查的需求，进一步促进了兽药市场的发展。

扩大畜牧业生产与动物健康管理：

为了满足全球对动物性蛋白质日益增长的需求，必须实施适当的健康管理措施，以确保动物福利和食品安全。对牲畜疾病有效预防和控制的需求刺激了对疫苗、抗菌药物和杀虫剂等兽药的需求，从而促使市场不断扩大。

主要问题

动物保健成本上升：

兽医服务和药品成本的上涨限制了宠物主人和牲畜生产者获得治疗的机会，尤其是在低收入地区。结果，高昂的医疗费用使人们不愿意定期去看兽医和预防性治疗，损害了动物的健康和福利，并对市场造成了重大障碍。

抗菌素抗药性（AMR）：

动物过度使用和滥用抗生素是抗菌药物抗药性日益严重的问题，对公共卫生构成重大风险。这项课题不仅导致了更严格的监管要求，还需要开发替代药物，从而影响动物保健市场对传染病的治疗方式。

供应链漏洞：

动物保健市场容易受到供应链中断的影响，进而影响关键药物和疫苗的供应。原料限制、物流瓶颈和地缘政治紧张都会造成供应限制，限製成功满足动物健康需求的能力并抑制市场扩张。

主要趋势：

远距医疗与数位健康平台：

远距医疗和数位健康平台允许远端咨询和监控，在兽医领域越来越受欢迎。该技术改善了人们获得兽医服务的机会，特别是在贫困地区，并透过使用应用程式和穿戴式装置促进了动物的持续健康管理。

个人化与精准医疗：

人们越来越重视个人化兽医学，它使用基因检测和现代诊断方法根据每隻动物的特定需求制定治疗方案。此策略可以改善治疗结果，最大限度地减少副作用，并允许更精确的疾病管理策略。

可持续且合乎道德的做法：

道德考量和永续性日益影响着动物保健市场。人们开始转向生产和消费生态友善且符合道德规范的产品。这一发展反映了消费者对动物照护程序透明度和责任感的更广泛渴望。

扩大兽医服务：

兽医诊所正在将其服务范围扩展到传统医疗保健之外，包括健康计划、营养建议、行为疗法和针灸等替代疗法。人们越来越意识到宠物和农场动物身心健康的重要性，从而转向全面的动物保健服务。

目录

第 1 章 全球动物保健市场简介

• 市场定义
• 市场区隔
• 调查安排
• 先决条件
• 限制

第 2 章：经过验证的市场研究方法

• 资料探勘
• 数据三角测量
• 由下而上的方法
• 自上而下的方法
• 调查流程
• 产业专家的重要见解
• 资料来源

第 3 章执行摘要

市场概况
• 生态製图
• 绝对的获利机会
• 市场吸引力
• 全球动物保健市场（按地区）分析
• 全球动物药品市场（依动物类型划分）
• 按产品类型划分的全球动物保健产品市场
• 未来市场机会
• 全球市场细分
• 产品生命线

第 4 章：动物保健产品全球市场展望

• 世界各地动物药物的演变
• 驱动程式
• 阻碍因素
• 机会
• 波特五力模型
• 价值链分析
• 价格分析
• 宏观经济分析

5. 全球动物药品市场（依动物类型）

• 概述
• 生产动物
• 伴侣动物

6. 全球动物保健产品市场（依产品类型）

• 概述
• 药品
• 疫苗
• 药物饲料添加剂

第 7 章。

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲国家
• 中东和非洲
  • 阿拉伯联合大公国
  • 沙乌地阿拉伯
  • 南非
  • 其他中东和非洲地区

第 8 章。

• 概述
• 各公司的市场排名
• 重大进展
• 公司地理分布
• 公司产业足迹
• ACE 矩阵

第九章 公司简介

• Zoetis Inc
• Virbac SA
• Soparfin SCA
• Merck & Co Inc
• Evonik Industries
• Elanco Animal Health Incorporated
• Dechra Pharmaceuticals PLC
• Ceva Sante Animale
• Boehringer Ingelheim International GmbH
• Archer Daniels Midland

第 10 章 经过验证的市场情报

关于经过验证的市场情报
• 动态资料视觉化

Veterinary Medicine Market Size And Forecast

Veterinary Medicine Market size was valued at USD 46.74 Billion in 2023 and is projected to reach USD 85.05 Billion by 2031, growing at a CAGR of 7.77% from 2024 to 2031. Veterinary medicine is a branch of medical science that studies the health and well-being of animals. It entails the diagnosis, treatment, prevention, and management of diseases and injuries in a wide variety of animal species, such as pets, cattle, wildlife, and zoo animals. Veterinary medicine addresses animals' particular health challenges by applying ideas and procedures from several disciplines such as anatomy, physiology, pathology, pharmacology, and surgery. Veterinarians play an important role in promoting animal welfare, protecting public health by controlling zoonotic diseases (those that can spread between animals and humans), ensuring food safety through livestock inspection and regulation, and contributing to scientific research.

Additionally, veterinary medicine goes beyond clinical care to include animal behavior, nutrition, reproduction, and epidemiology, addressing the overall health needs of both individual animals and animal groups.

Global Veterinary Medicine Market Dynamics

The key market dynamics that are shaping the veterinary medicine market include:

Key Market Drivers

Rising Pet Ownership and Humanization:

The growing global trend of pet ownership, combined with the humanization of pets such that they are considered members of the family, boosts demand for veterinary medicine. This tendency encourages more frequent and comprehensive pet healthcare and wellness checkups, hence increasing demand for veterinarian products and services.

Advancements in Veterinary Healthcare:

Technological advances in animal diagnostics, medicines, and immunizations improve the effectiveness and efficiency of veterinary treatment. Telemedicine, wearable health monitors, and sophisticated surgical procedures help to develop the veterinary medical market by improving treatment outcomes and broadening the range of services available, fueling market growth.

Growing Awareness of Animal Health and Welfare:

Pet owners and farmers are becoming more conscious of the importance of animal health and welfare, which has led to proactive and preventive healthcare methods. This increased awareness is fueling demand for immunizations, nutritional supplements, and regular health screenings, boosting the veterinary medicine market even further.

Expansion of Livestock Production and Farm Animal Health Management:

To meet the expanding worldwide demand for animal protein, appropriate health management methods must be implemented to ensure animal welfare and food safety. The requirement for effective disease prevention and control in farm animals is fueling the demand for veterinary medicines such as vaccinations, antimicrobials, and parasiticides, resulting in market expansion.

Key Challenges:

Rising Costs of Veterinary Care:

The rising expense of veterinary services and medications restricts access to treatment for pet owners and livestock producers, particularly in regions with low incomes. Thus, high costs discourage regular veterinary visits and preventive treatments, compromising animal health and welfare, and posing a significant hurdle for the market.

Antimicrobial Resistance (AMR):

Overuse and misuse of antibiotics in animals contribute to the growing problem of AMR, which poses a substantial public health risk. This difficulty needs the development of alternate medicines as well as tight regulatory requirements, which will have an impact on the way the veterinary medicine market treats infectious diseases.

Supply Chain Vulnerabilities:

The veterinary medication market is vulnerable to supply chain disruptions, which impact the availability of critical medicines and vaccines. Raw material limitations, logistical obstacles, and geopolitical tensions all cause supply limits, limiting the ability to successfully meet the demand for veterinary care, and inhibiting market expansion.

Key Trends:

Telemedicine and Digital Health Platforms:

Telemedicine and digital health platforms are becoming increasingly popular in veterinary care, allowing for remote consultations and monitoring. This technology improves access to veterinary services, particularly in poor areas, and promotes continuing health management for animals using applications and wearable devices.

Personalized and Precision Medicine:

There is a rising emphasis on personalized veterinary medicine, which uses genetic testing and modern diagnostics to adapt therapies to the unique needs of each animal. This strategy enhances treatment outcomes, minimizes adverse effects, and allows for more accurate disease management tactics.

Sustainable and Ethical Practices:

Ethical considerations and sustainability are increasingly influencing the veterinary care market. There is a shift towards creating and consuming ecologically friendly and ethically sourced items. This development reflects a broader consumer desire for transparency and accountability in animal care procedures.

Expansion of Veterinary Services:

Veterinary practices are expanding their services beyond traditional treatment to include wellness programmes, nutritional advice, behavioural therapy, and alternative therapies such as acupuncture. This shift towards comprehensive animal healthcare services is being pushed by a growing realization of the importance of mental and physical well-being in pets and livestock.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Veterinary Medicine Market Regional Analysis

Here is a more detailed regional analysis of the veterinary medicine market:

North America:

According to Verified Market Research, North America is estimated to dominate the veterinary medicine market over the forecast period. North America, especially the United States, has one of the highest pet ownership rates in the world. This large pet population creates a high demand for veterinarian services and products like of wellness checkups, surgical treatments, and medications, bolstering the region's supremacy in the veterinary medicine market.

The region has a well-developed veterinary healthcare infrastructure, which includes cutting-edge veterinary hospitals, clinics, and research facilities. This enhanced infrastructure enables the delivery of cutting-edge therapies and breakthroughs in animal health care, hence contributing to the market's expansion and development.

Furthermore, North American consumers are highly aware of the importance of pet and animal health and are willing to invest accordingly. The cultural relevance of pets as family members results in large spending on preventative care, diagnostics, and treatments, boosting the region's veterinary medicine market growth.

Europe:

Europe is home to some of the world's best veterinary research facilities and pharmaceutical businesses, which have helped to develop veterinary care significantly. Continuous investment in R&D yields breakthrough medicines and diagnostic tools, moving the veterinary medicine market ahead.

The trend of pet humanization is especially prominent in Europe, where an increasing percentage of households' pets and treated like family members. This leads to increased spending on pet healthcare, such as preventive care, wellness products, and specialized treatments, driving market expansion.

Furthermore, the rising knowledge of zoonotic illnesses in Europe, particularly following occurrences such as the COVID-19 pandemic, is shifting the emphasis to animal health as a component of public health. This increased awareness regarding zoonotic disease immunizations, diagnostics, and treatments is propelling the veterinary medicine market.

Asia Pacific:

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The region's expanding population and rising wages have raised the demand for animal protein, resulting in a major expansion in the cattle business. This expansion needs improved animal health management methods, such as preventive care and immunizations, bolstering the veterinary medication market.

Government policies and consumer demand are driving an increase in awareness and concern for animal health and welfare throughout Asia Pacific. This increased attention encourages the adoption of better healthcare practices for both pets and cattle, contributing to market growth.

Furthermore, government and corporate sector investments in veterinary healthcare infrastructure, like as hospitals, clinics, and research centers, are increasing across the Asia-Pacific region. These expenditures provide access to veterinary services and encourage the adoption of innovative healthcare technology, hence moving the veterinary medicine market forward.

Global Veterinary Medicine Market: Segmentation Analysis

The Global Veterinary Medicine Market is Segmented on the basis of Product, Animal Type, Route of Administration, Distribution Channel, and Geography.

Veterinary Medicine Market, By Product

• Drugs
• Vaccines

Based on the Product, the market is segmented into Drugs and Vaccines. The vaccines segment is estimated to dominate the veterinary medicine market. Vaccines serve an important role in preventative veterinary care because they provide protection against a wide range of infections, lowering disease outbreaks, and the need for antibiotic treatments, and eventually leading to healthier animal populations. The increased focus on animal welfare, combined with rigorous legislation for immunization of pets and animals, spurring up demand for vaccinations.

Veterinary Medicine Market, By Animal Type

• Domesticated
• Companion

Based on the Animal Type segment, the market is segmented into Domesticated and Companion. The companion animal type segment is estimated to dominate the veterinary medicine market during the forecast period due to the growing tendency of pet humanization, in which pets are increasingly seen as full members of the family. As a result, pet owners are increasingly ready to invest in their pets' health and well-being, boosting demand for a diverse variety of veterinarian services and products such as preventive immunizations, diagnostics, medicines, and nutritional supplements. Furthermore, the rise in pet ownership rates, particularly in affluent countries, is stirring up the demand for companion animal veterinarian care.

Veterinary Medicine Market, By Route Of Administration

• Oral
• Parental

Based on the Route of Administration, the market is segmented into Oral and Parental. The parental segment is estimated to exhibit the highest growth within the veterinary medicine market. The parenteral route, which includes intravenous, intramuscular, and subcutaneous injections, is critical for delivering drugs directly into the bloodstream, resulting in a faster and more regulated response than oral routes. This is especially important in treating severe or acute illnesses that require quick absorption. Parenteral treatments have a considerable market share due to their dependability and efficacy in critical care circumstances, even though they require professional administration and can cause animals more stress than oral alternatives.

Veterinary Medicine Market, By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Stores
• Online Pharmacies

Based on the Distribution Channel, the market is segmented into Veterinary Hospitals and Clinics, Retail Stores and Online Pharmacies. The veterinary hospitals & clinics segment is estimated to dominate the veterinary medicine market due to the comprehensive care and broad variety of services provided by these hospitals, which include diagnostic, treatment, surgery, and emergency care. Veterinary hospitals and clinics are the first point of contact for pet owners and livestock producers looking for expert, specialized treatment for their animals. They not only provide fast access to a wide range of veterinary pharmaceuticals, such as prescription drugs, vaccines, and treatments, but also the experience of veterinary professionals to ensure proper diagnosis and treatment regimens.

Veterinary Medicine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the veterinary medicine market is classified into North America, Europe, Asia Pacific, and the Rest of the world. According to the VMR analyst, North America is estimated to dominate during the forecasted period. This region has a strong and advanced veterinary healthcare infrastructure, which includes world-class veterinary hospitals, clinics, and research institutions that help deliver cutting-edge care and encourage veterinary medicine advances. Furthermore, strong regulatory standards maintain high-quality care and product safety, which strengthens consumer trust and market stability.

Key Players

• The "Veterinary Medicine Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Zoetis, Merck & Co., Elanco, Boehringer Ingelheim, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Phibro Animal Health Corporation, Inventory Ally, Virbac, Bimeda Corporate, Chewy, Vetoquinol SA, Neogen Corporation, China Animal Husbandry Co., Sanofi SA, Loyal Companion, Bayer Animal Health, IDEXX Laboratories, Royal Canin SAS and Nestle Purina PetCare Company.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Veterinary Medicine Market Recent Developments
• In February 2024, Chewy, an online pet retailer, announced plans to construct brick-and-mortar veterinarian clinics in Florida and Colorado, further increasing its influence in the pet healthcare market.
• In February 2024, Loyal Companion, a pet health company, announced that they are looking for senior dogs to participate in a study that will assess the efficacy of a prospective canine longevity medicine.
• In February 2024, Inventory Ally, a cloud-based software system, won the 2024 Pet Pitch Prize competition for its contribution to streamlining inventory management and purchasing in veterinary facilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VETERINARY MEDICINE MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Veterinary Medicine Market Geographical Analysis (CAGR %)
• 3.6 Global Veterinary Medicine Market, By Animal Type (USD Million)
• 3.7 Global Veterinary Medicine Market, By Product Type (USD Million)
• 3.8 Future Market Opportunities
• 3.9 Global Market Split
• 3.10 Product Life Line

4 GLOBAL VETERINARY MEDICINE MARKET OUTLOOK

• 4.1 Global Veterinary Medicine Evolution
• 4.2 Drivers
  • 4.2.1 Driver 1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint 1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity 1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

• 5.1 Overview
• 5.2 Production Animals
• 5.3 Companion Animals

6 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Drugs
• 6.3 Vaccines
• 6.4 Medicated Feed Additives

7 GLOBAL VETERINARY MEDICINE MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle-East and Africa
  • 7.6.1 UAE
  • 7.6.2 Saudi Arabia
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL VETERINARY MEDICINE MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Developments
• 8.4 Company Regional Footprint
• 8.5 Company Industry Footprint
• 8.6 ACE Matrix

9 COMPANY PROFILES

• 9.1 Zoetis Inc
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Product Benchmarking
  • 9.1.4 Key Development
  • 9.1.5 Winning Imperatives
  • 9.1.6 Current Focus & Strategies
  • 9.1.7 Threat from Competition
  • 9.1.8 SWOT Analysis
• 9.2 Virbac SA
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Product Benchmarking
  • 9.2.4 Key Development
  • 9.2.5 Winning Imperatives
  • 9.2.6 Current Focus & Strategies
  • 9.2.7 Threat from Competition
  • 9.2.8 SWOT Analysis
• 9.3 Soparfin SCA
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Product Benchmarking
  • 9.3.4 Key Development
  • 9.3.5 Winning Imperatives
  • 9.3.6 Current Focus & Strategies
  • 9.3.7 Threat from Competition
  • 9.3.8 SWOT Analysis
• 9.4 Merck & Co Inc
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Product Benchmarking
  • 9.4.4 Key Development
  • 9.4.5 Winning Imperatives
  • 9.4.6 Current Focus & Strategies
  • 9.4.7 Threat from Competition
  • 9.4.8 SWOT Analysis
• 9.5 Evonik Industries
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Product Benchmarking
  • 9.5.4 Key Development
  • 9.5.5 Winning Imperatives
  • 9.5.6 Current Focus & Strategies
  • 9.5.7 Threat from Competition
  • 9.5.8 SWOT Analysis
• 9.6 Elanco Animal Health Incorporated
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Product Benchmarking
  • 9.6.4 Key Development
  • 9.6.5 Winning Imperatives
  • 9.6.6 Current Focus & Strategies
  • 9.6.7 Threat from Competition
  • 9.6.8 SWOT Analysis
• 9.7 Dechra Pharmaceuticals PLC
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Product Benchmarking
  • 9.7.4 Key Development
  • 9.7.5 Winning Imperatives
  • 9.7.6 Current Focus & Strategies
  • 9.7.7 Threat from Competition
  • 9.7.8 SWOT Analysis
• 9.8 Ceva Sante Animale
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Product Benchmarking
  • 9.8.4 Key Development
  • 9.8.5 Winning Imperatives
  • 9.8.6 Current Focus & Strategies
  • 9.8.7 Threat from Competition
  • 9.8.8 SWOT Analysis
• 9.9 Boehringer Ingelheim International GmbH
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Product Benchmarking
  • 9.9.4 Key Development
  • 9.9.5 Winning Imperatives
  • 9.9.6 Current Focus & Strategies
  • 9.9.7 Threat from Competition
  • 9.9.8 SWOT Analysis
• 9.10 Archer Daniels Midland
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Product Benchmarking
  • 9.10.4 Key Development
  • 9.10.5 Winning Imperatives
  • 9.10.6 Current Focus & Strategies
  • 9.10.7 Threat from Competition
  • 9.10.8 SWOT Analysis

10 VERIFIED MARKET INTELLIGENCE

• 10.1 About Verified Market Intelligence
• 10.2 Dynamic Data Visualization